{
  "name" : "twin.sci-hub.se_7159_325820f425e056b92b1139a90ebf1e9d_katouzian2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients",
    "authors" : [ "Iman Katouzian", "Afshin Faridi Esfanjani", "Seid Mahdi Jafari", "Sahar Akhavan" ],
    "emails" : [ "smjafari@gau.ac.ir" ],
    "sections" : [ {
      "heading" : null,
      "text" : "lable at ScienceDirect\nContents lists avai\nTrends in Food Science & Technology journal homepage: ht tp: / /www.journals.e lsevier .com/trends- in- food-science-\nand-technology\nReview\nFormulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients\nIman Katouzian a, Afshin Faridi Esfanjani b, Seid Mahdi Jafari c, *, Sahar Akhavan c\na Young Researchers and Elites Club, Science and Research Branch, Islamic Azad University, Tehran, Iran b Young Researchers and Elites Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran c Department of Food Materials and Process Design Engineering, Gorgan University of Agricultural Science and Natural Resources, Gorgan, Iran\na r t i c l e i n f o\nArticle history: Received 8 December 2016 Received in revised form 23 June 2017 Accepted 24 July 2017 Available online 25 July 2017\nKeywords: Solid lipid nanoparticles (SLNs) Nanostructured lipid carriers (NLCs) Food industry Delivery systems Formulation\n* Corresponding author. E-mail address: smjafari@gau.ac.ir (S.M. Jafari).\nhttp://dx.doi.org/10.1016/j.tifs.2017.07.017 0924-2244/© 2017 Elsevier Ltd. All rights reserved.\na b s t r a c t\nBackground: Lipid nanoparticles are innovative delivery systems, which are similar to the prevalently used emulsions, with the differences in size and structure in which the water-insoluble core is dispersed in a combination of solid and liquid lipids stabilized by surfactants. Solid lipid nanoparticles (SLNs) plus nanostructured lipid carriers (NLCs) are novel and promising nano-vehicles, which are of great interest to be applied in the food sector owing to their exclusive properties, as investigated in this revision. Scope and approach: LNs and NLCs are produced to unite the advantages of structures like liposomes and emulsions and they can be formulated to achieve desirable protection and release of food bioactive ingredients. This review highlights the pros and cons of using SLNs and NLCs in the food industry. Furthermore, the commonly applied production methods and formulations along with the recently conducted studies in the field of food science and technology are underlined. Key findings and conclusions: These nano-vehicles have the potential to be employed in the food industrial applications in regard to their beneficial properties like simple production technology, low cost and scale up ability. These nanocarriers have been mostly applied in the pharmaceutical industries and are recently being utilized in the food sector, which seems to have great impacts on this industry as well as their commercialization in the near future.\n© 2017 Elsevier Ltd. All rights reserved."
    }, {
      "heading" : "1. Introduction",
      "text" : "Today, the benefits of nanotechnology has influenced many branches in the food sector such as, packaging, bioactives compound delivery systems, and designing optimized formulations with the aim of increased bioavailability (Gibbs et al., 1999). Nanoencapsulation of food ingredients via various nanocarriers may elevate the stability and viability of bioactives as well as other applications to improve the quality of food products. The nanoencapsulation bodies can be carbohydrate, protein or lipid based. Carbohydrate and protein networks are not suitable for industrial purposes because of the execution of intricate chemical or heat processing, which cannot be entirely controlled (Fathi, Mozafari, & Mohebbi, 2012). On the other hand, lipid-based nanoparticles bear the advantages of (Fathi et al., 2012; Mohammadi, Jafari, Esfanjani, & Akhavan, 2016a):\nbiocompatibility more encapsulation efficiency targeted effect modified release low toxicity lack of organic solvent for the formulation ease of continuous production\nThat is why recent investigations are focused on lipid-based carriers to be applied in pharmaceutical and food sectors. Lipidbased nanocarriers in the food industry encompass nanospheres, nanoliposomes, nanoemulsions and lipid nanoparticles with solid/ liquid networks including Solid lipid nanoparticles (SLNs) and Nanostructured lipid carriers (NLCs) (Fang, Fang, Liu, & Su, 2008).\nMost of the bioactives and nutrients; such as polyphenols, carotenoids, lipophilic vitamins, phytosterols, etc. are naturally hydrophobic. In addition, the absorption of bioactives is facilitated in the small intestine if it is accompanied with an edible lipid due to the amplification in the content of mixed micelles responsible for the solubilization and transportation of lipophilic agents (Porter,\nTrevaskis, & Charman, 2007; Pouton, 2006). In comparison to other lipid-based nanocarriers, such as nanoliposomes and nanoemulsions, SLNs and NLCs have lately attracted much attention from the food and pharmaceutical industries due to their advantages. A schematic representation of these carriers is shown in Fig. 1.\nHowever, the benefits of using NLCs and SLNs are not completely proved yet and there are several unanswered questions concerning this topic. For instance, do the release kinetics and profile differ between SLNs and NLCs? Does different guestmolecule loading affect the release profile in SLNs and NLCs? How is the stability of NLCs at various storage conditions compared to SLNs? How does the administration route affect the release profile in both nanovehicles (Kovacevic, Savic, Vuleta, Müller, & Keck, 2011)? Therefore, further studies should be designed and executed to answer these questions and elucidate the future applications of these nanocarriers in the food sector (Das, Ng, & Tan, 2012).\nIn this review paper, the latest progress made in the nanoencapsulation of nutrients within the SLNs and NLCs networks are discussed. Also, the production techniques, physicochemical features, release profiles and modeling plus their functions within the food systems are explored. Finally, recent studies and applications of SLNs and NLCs in the field of food and nutraceutical industries are provided."
    }, {
      "heading" : "2. Solid lipid nanoparticles (SLNs)",
      "text" : "Among the mentioned lipid nanoparticles, SLNs contain lipid droplets that are fully crystallized and have an organized crystalline structure with the bioactive components accommodated within the lipid matrix (Weiss et al., 2008). The advent of SLNs dates back to 1990 when these nano-structures were manufactured by replacing the liquid state lipid (oil) with the solid one in the emulsion and thus the lipids are solid at ambient temperature as well as the body temperature (Müller, Radtke, &Wissing, 2002a,b). SLNs are novel nanoparticulate vehicles developed to overcome the drawbacks of other nano lipid-based carriers, such as nanoliposomes, nanoemulsions, etc. According to (Mu Eller, Ma Eder, & Gohla, 2000), SLNs are able to prolong the release period according to their solid state, protecting the active agents against unwanted chemical reactions like oxidation. Some of the advantages of the employment of SLNs as efficient nanovehicles are listed below (Madureira et al., 2015; Mozafari, 2006; Sagalowicz & Leser, 2010).\nHigh entrapment efficiency Organic solvents are not used in the production methods Being low-cost and simple so as to make it possible for largescale manufacturing Able to protect the core bioactive compounds (both lipophilic and hydrophilic) against external harsh conditions Providing a flexible release profile via their solid matrix Prolonged release due to slow disintegration Can be utilized in both liquid and solid state food products No biotoxicity is considered for these carriers as they are made from naturally occurring food components.\nHowever, like other nanocarriers, SLNs also have their own disadvantages which are (Aditya & Ko, 2015; Weiss et al., 2008):\nPossible gelation phenomenon Unexpected transitions in fat crystalline structures leading to the expulsion of core materials during storage Assembly and growth of particles Low capacity for the incorporation of bioactives within the nanoparticles."
    }, {
      "heading" : "2.1. Structure of SLNs",
      "text" : "SLNs are formulated from one solid lipid or a blend of solid lipids. In general, the mobility of bioactive components can be controlled by altering the physical state of the lipid matrix within the SLNs (Müller et al., 2002a,b). The bioactive substance has a much lower diffusion rate within these applicable nanovehicles hence prolonged release occurs. According to Üner (2006), the dispersion of the bioactive compounds inside the SLNs is classified into three types (Fig. 2) known as solid solution model, bioactive enriched shell and bioactive enriched core.\nIn the first model, the bioactive ingredients are dispersed throughout the lipid matrix; in addition, no surface active agent and surfactant are used for the fabrication of this type. Considering the bioactive-enriched shell type, the bioactive ingredients are transferred to the water phase because of partitioning during the hot homogenization preparation. The partitioning rate scales directly with the solubility of the bioactive ingredient in the water phase as well as increase in temperature. After the cooling process, the solubility of the bioactive ingredient in the water phase decreases gradually and re-partitioning occurs in a way that the bioactive compounds are transferred to the lipid phase owing to their decreased solubility in water. Ultimately, the bioactive compounds are located in the external shell/surface of the SLNs. The third and last type is the bioactive-enriched core model in which the bioactive ingredient is dissolved in the molten lipid nearly to its saturation level. Afterwards, the cooling process of the mixture results in the supersaturation of the bioactive ingredient in the molten lipid and its precipitation before the recrystallization of lipids. In this mode of entrapment, the level of the SLN related bioactive ingredient is associated with the nature and concentration of the surfactant encircling the SLN's core."
    }, {
      "heading" : "2.2. Application of SLNs in the food industry",
      "text" : "SLNs, as the modern type of nano lipid carriers have found their way in different fields. Because of their remarkable stability and high loading capacity, they are widely applied in the pharmaceutical and cosmetic fields. Nevertheless, reports about their application in functional food industries were greatly limited concerning the following considerations (Jaiswal, Gidwani, & Vyas, 2016):\n✓ SLNs are particularly suitable for encapsulating and delivery of lipophilic bioactive compounds, such as flavors, biocidal compounds and drugs into aqueous-based foods. Yet, incorporating hydrophilic bioactives in lipid nanoparticles is difficult due to the tendency of partitioning, related to the encapsulated molecules in the water during the production process of nanoparticles (Singh, Dobhal, Jain, Pandit, & Chakraborty, 2010). ✓ SLNs can be formulated on an industrial scale but GRAS or foodgrade ingredients are required. Since many substances that are utilized in the pharmaceutical industries are not allowed in food in large quantity, further studies are then required for the selection of appropriate materials to be incorporated within the food systems (Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2013). ✓ The ingredients should not have a negative effect on the sensory properties of SLNs-incorporated foods (Du, 2011). ✓ Stability of SLNs must be examined during processing and storage of foods against mechanical and physicochemical stresses, such as pressure, stirring, thermal processing, light, drying, freezing, pH, and environmental storage conditions (Tamjidi et al., 2013). ✓ SLNs should remain solid at room and GI tract temperatures. The solid lipid, like liquid lipid, can be digested in the body by lipase but its digestion rate is much lower in comparison to the liquid state lipid (McClements & Li, 2010). Moreover, if the bioactive is introduced to the crystalline form inside the lipid nanoparticle, its bioavailability may decrease than that of non-crystalline form.\nNevertheless, the usage of SLNs in the food area has developed greatly. SLNs are practical delivery systems for lipophilic nutraceuticals, which may increase their stability and bioavailability as well as dispersibility in aqueous media e.g. beverages. Hence, as enlisted in Table 1, a broad range of bioactive compounds have been tested and incorporated into these versatile nano-delivery systems for various food applications, such as a-tocopherol in glyceryl behenate (de Carvalho et al., 2013), beta-carotene in 50:50 cocoa butter and hydrogenated palm oil (Qian, Decker, Xiao, & McClements, 2013), resveratrol in stearic acid (Pandita, Kumar, Poonia, & Lather, 2014), rosmarinic acid within carnauba wax (Madureira et al., 2015), curcuminoids in tristearin, trimyristin and glyceryl monostearate (Nayak, Tiyaboonchai, Patankar, Madhusudhan, & Souto, 2010), copaiba oil and allantoin in cetyl palmitate (Svetlichny et al., 2015), Zataria multiflora essential oil within glyceril mono stearate and Precirol® ATO 5 (Nasseri, Golmohammadzadeh, Arouiee, Jaafari, & Neamati, 2016) and\npeppermint essential oil loaded in fully hydrogenated soybean oil (Yang& Ciftci, 2016). These investigations reflect the enhanced rate of bioavailability plus the stability of the active compounds being entrapped in SLNs. Furthermore, the encapsulation efficiency, size, stability and other characteristics may be altered as a result of the emulsifier type and amount, nano-lipid vehicle type, environmental factors and temperature."
    }, {
      "heading" : "3. Nano-structured lipid carriers (NLCs)",
      "text" : "NLCs, as another type of lipid-based vehicles entered the nanoencapsulation field lately to cover the deficiencies found in SLNs. The main purpose was to enhance the loading capacity and to inhibit the expulsion of bioactive compounds. These nanovehicles are produced by dispersion of a mixture of solid and liquid lipids plus the bioactive ingredients (as inner phase) in water along with emulsifiers (as outer phase). In contrast to SLNs, the presence of liquid lipid in inner phase of NLCs causes the possibility of entrapping bioactive ingredients, which are better solubilized in liquid lipid. On the other hand, the mixture of lipids in NLCs causes slower polymorphic transition and low crystallinity index. In brief, the composition of inner phase of NLCs can provide higher loading capacity, higher encapsulation efficiency, and higher bioavailability of nano-encapsulated ingredients in comparison to SLNs (Müller et al., 2002a), which were described in the previous section. Hence, this section provides some main information about formulation, structure, and application of NLCs.\nSome of the advantages of employing NLCs in the nanoencapsulation of food components are (Fathi et al., 2012; http:// www.pharmasol-berlin.de/lipidnano.php3; Müller et al., 2002a):\nMore available space for the accommodation of bioactives More loading content Higher solid content (30e50%) may be formed in the suspensions Enhanced dosage of the core material in the produced nanocapsules"
    }, {
      "heading" : "3.1. Structure of NLCs",
      "text" : "The structure of NLCs with respect to the aim of nanoencapsulation, makeup, production methods, and type of core materials can be classified in three different morphologies (Müller et al., 2002a), which are imperfect crystal, amorphous and multiple\nTable 1 List of bioactive compounds incorporated into SLNs applied in the food industry.\nBioactive compound\nLipid formulation Method of preparation Results Reference\nPeppermint essential oil\nFully hydrogenated soy bean oil Atomization of CO2-expanded lipid mixture The obtained novel hollow solid lipid nanoparticles are effective alternatives to the solid lipid nanoparticles, and to overcome the issues associated with the solid lipid nanoparticles (Yang & Ciftci, 2016)\nZataria multiflora essential oil (ZEO)\nGlyceryl mono stearate and precirol® ATO 5 High shear homogenization and ultrasonication The ZEO and ZEO-loaded SLNs\nhad 54 and 79% inhibition on the growth of fungal pathogens, respectively\n(Nasseri et al., 2016)\nVitamin B2 Fully hydrogenated canola oil Supercritical co-injection process and production of particles from gas-saturated solutions (PGSS) It is possible to generate nanoscale solid lipid particles with a high content of a hydrophilic bioactive; however, further fine tuning is needed (Couto, Alvarez, & Temelli, 2017) Vitamin B12 Compritol® Hot homogenization The bioactive ingredient release efficiency of vitamin B12 by means of SLNs increased up to 3 h (Genç, Kutlu, & Güney, 2015) Palm or coconut oil Palm or coconut oil High speed homogenization plus ultrasonication Viability of L. plantarum of palm or coconut oil SLNs in ultra-high temperature milk was higher than that of SLNs in distilled water (Jo, Choi, & Kwon, 2015) Copaiba oil and allantoin\nCopaiba oil and cetyl palmitate High homogenization Nanoencapsulation improved the antifungal activity of copaiba oil, which was enhanced by the presence of allantoin (Svetlichny et al., 2015)\nRosmarinic acid Carnauba wax Hot melt ultrasonication The optimum range values to obtain highly stable formulations included 1.0 and 1.5% (w/v) of lipid and 2% (v/v) of ploysorbate 80 (Madureira et al., 2015) Resveratrol Stearic acid/poloxamer 188 Solvent diffusion-solvent evaporation The lipid formulation produced a significant improvement in the oral bioavailability of resveratrol as compared to the intact suspension (Pandita et al., 2014) Hesperetine Glycerol monostearate, stearic acid, glyceryl behenate and oleic acid\nHigh mechanical shear The bitter taste of hesperetine fortified milk samples was well masked and poor solubility of hesperetine was declined (Fathi, Varshosaz, Mohebbi, & Shahidi, 2013)\nb-carotene Cocoa butter and hydrogenated palm oil Hot high pressure homogenization Solid lipid nanoparticles may not be better than liquid lipid nanoparticles for encapsulation of bioactive food ingredients. (Qian et al., 2013) a-tocopherol Glyceryl behenate/soy lecithin Hot high pressure homogenization The stability of the SLN formulation was improved as well as the retention of atocopherol (de Carvalho et al., 2013) Vitamin D2 (ergocalciferol)\nTripalmitin Hot homogenization As the concentration of vitamin D2 increased, a clear dispersion was obtained, which is practical for the fortification of milk and margarine (Patel, Martin-Gonzalez, & Fernanda, 2012)\ncategories as shown in Fig. 3. In the First model, using different lipids with distinct dimensions may lead to higher distances between the lipids and therefore more guest agents are accommodated among the lipid structures. In order to achieve the best results, solid lipids are mixed with oils (liquid state); this model is known as the imperfect type NLC. In SLNs, the bioactive ingredients are incorporated in limited space due to the perfect crystal lattice of solid lipid matrix and induce the expulsion of the nano-encapsulated ingredient. In contrast, the application of a combination of lipids containing liquid and solid lipid renders an imperfect crystal in NLCs and the bioactive ingredients are incorporated in the amorphous building\nblocks. Thus, the barriers of SLNs can be removed by deviation of crystallization. The imperfection rate can be increased by using a mixture of glycerides with variable fatty acid chains that form a solid matrix with fluctuating distances best suited for the accommodation of bioactive compounds (Müller et al., 2002a).\nIn the second model termed as multiple type NLCs, bioactives which are more soluble in oils than solid lipids are dissolved in oils, therefore they are not decomposed by the solid lipids. To minimize the expulsion of nano-encapsulated ingredients, NLCs can be fabricated by blending solid lipids with certain lipids, such as hydroxyoctacosanylhydroxystearate, isopropyl myristate or MCT. In this manner, the non-crystalline lipid nanoparticles are formed in\nwhich the lipid core congeals in the form of an amorphous body. This is an amorphous type of NLC and can be used for the retardation of release of nano-encapsulated ingredients by maintaining the polymorphicity of the lipid matrix (Müller et al., 2002a).\nLastly, the third group called amorphous type NLCs, does prevent the problem of expulsion induced by the crystallization of solid lipids. Here, crystallization is reduced after cooling by blending particular lipids, such as isopropyl myristate and hydroxyl stearate. In other words, the third type of NLCs namely multiple is an oil in solid lipid in water solution (like the water in oil in water emulsions). These multiple networks are especially applied to the entrapment of ingredients being highly soluble in liquid lipids. Indeed, the liquid lipid nano-compartments contain labile ingredients that are scattered in a solid-state lipid matrix. Hence, the release of a high amount of bioactive compounds inside the liquid lipid nano-compartments may be regulated by the encircling solid lipid barrier. Generally, in the production phase of multiple NLCs, two basic points should be taken into account: selection of appropriate liquid and solid lipid for complete miscibility and mixing a solid lipid with a higher amount of liquid lipid. The liquid lipid nano-compartments are created by phase separation. This occurs during cooling step of production; NLCs contain a high amount of liquid lipids by the hot homogenization method, the solubility of the liquid lipid in the solid lipid matrix is exceeded and the nano-droplet of liquid lipid being incorporated into the solid lipid matrix (Müller et al., 2002a)."
    }, {
      "heading" : "3.2. Application of NLCs in the food industry",
      "text" : "NLCs are one of the practical delivery systems not only in food but also in the cosmetic and pharmaceutical industries. The bioavailability, penetration, absorption, protection and release of bioactive ingredients can be optimized by their encapsulation in NLCs. So, NLCs are introduced as fine lipid-based systems for delivery of drugs to different organs of the body and to prepare functional foods. Currently, NLCs are widely employed as practical delivery systems and their final structure depends on the purpose of encapsulation plus the type of the encased ingredient.\nLately, the public interest of healthy foods namely functional has dramatically extended. Functional foods are fortified by bioactive ingredients, such as antioxidant, antimicrobial, antidiseases, essential oils, natural coloring and flavoring agents, etc. (Chen,\nWeiss, & Shahidi, 2006). Meanwhile, these bioactive ingredients are prone to degradation by environmental stresses (e.g., pH, light, oxygen, and etc.), expulsion from the vector, rapid excretion from the body and low absorption by intestinal cells. Therefore, the bioactive ingredients are encased by practical vehicles in order to protect them against undesirable factors and produce fortified food products. NLCs, as one of the lipid-based encapsulation vehicles, can be successfully used as a fundamental delivery system for the fortification of foods accommodating a variety of bioavailable ingredients (Fathi et al., 2012).\nUp to now,many investigations have been carried out in order to encapsulate nutrients within the NLCs. Some of the recent studies performed in this area are entrapment of alpha-lipoic acid in glycerin monostearate and glyceride (Wang, Tang, Zhou, & Xia, 2014), astaxanthin in glyceryl behenate and oleic acid (Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2014), beta-carotene in palmitic acid and corn oil (Hejri, Khosravi, Gharanjig, & Hejazi, 2013), quercetin in glyceryl monostearate and caprylic capric triglyceride (Ni, Sun, Zhao, & Xia, 2015), green tea extract in glyceryl stearate, cetyl palmitate, grape seed oil and sea buckthorn oil (Manea, Vasile, & Meghea, 2014), rutin in cocoa butter and oleic acid (Babazadeh, Ghanbarzadeh, & Hamishehkar, 2016), mono, di and triterpenes in beeswax together with caprylic/capric triglyceride (Laso n, Sikora, Ogonowski, Tabaszewska, & Skoczylas, 2016), cold pressed fruit and kernel seed oils in paraffin oil, beeswax, glycerol and mono, di and tri acylglycerols (Krasodomska, Paolicelli, Cesa, Casadei, & Jungnickel, 2016), Brucea javanica oil incorporated in glyceryl monostearate, medium-chain triglyceride, stearic acid plus Cremophor EL (Lv et al., 2016), and curcumin accommodation within soybean phospholipids, glyceryl monostearate, medium chain triglyceride and steric acid with the aim of improving oral delivery (Chanburee & Tiyaboonchai, 2016).\nMore information about the food application of NLCs and some recently pursued investigations in this area are gathered in Table 2."
    }, {
      "heading" : "4. Formulation of SLNs and NLCs",
      "text" : "The SLNs and NLCs as nano-scale delivery systems are basically composed of an inner phase containing lipids (solid or solid and liquid), surface active materials (emulsifiers), and water. These systems are derived from O/W emulsion, with the exception that the inner phase of SLNs contain 100% solid lipid and NLCs contain\n30% liquid lipid (oil) and 70% solid lipid. The solid lipids have a melting point above room and body temperature, but the liquid lipid exhibits a melting point much lower than the ambient and body temperature. Besides, the application of suitable emulsifiers is necessarily needed for achieving a fine dispersion of these lipids in water medium. Therefore, an effectively engineered delivery system of bioactive ingredients by SLNs and NLCs can be provided by the accurate and pre-designed formulation of lipids, emulsifiers, and water (Katouzian & Jafari, 2016; Wissing, Kayser, & Müller, 2004). In the following subsections, more details have been presented on these components."
    }, {
      "heading" : "4.1. Lipids",
      "text" : "The lipid matrix is a fundamental element in SLNs and NLCs so that bioactive ingredients could be incorporated in this matrix. Therefore, the appropriate selection of lipids is necessary for the entrapment of bioactive ingredients. There are some items that should be considered in regard to the lipids being utilized in the formulation of SLN and NLC structures, which include:\nGood solubility of lipophilic ingredients within the lipid matrix High stability against decomposition factors, such as oxidation Being biodegradable, health-promoting and safe\nA rational proportion between the solid and liquid lipids in the matrix (for NLCs).\nThe common solid lipids (rigid at the ambient and body temperature) used in SLNs and NLCs include glyceryl behenate (Compritol®888 ATO), glyceryl monostearate (monostearate), glyceryl palmitostearate plus stearic acid. Compritol®888 ATO is an amphiphilic material with a relatively high melting point (~70 C). The employment of Compritol®888 ATO in NLCs bring numerous benefits, such as enhanced encapsulation efficiency, increased physical stability plus the reduction in the rate of unwanted release, which can be attributed to the labile a-polymorphic form in the crystalline lattice (Souto, Mehnert, & Müller, 2006). Nonetheless, formulating NLCs with narrow size distribution is somehow complicated due to higher melting point and viscosity of Compritol®888 ATO. In contrast, the small and narrow-size-distributed NLCs can be obtained by compounds like monostearin. Monostearin is also used as an emulsifier, which is able to induce a controlled release behavior (Zhuang et al., 2010).\nGlyceryl palmitostearate has a high melting point (52e55 C) and can be used to modify the release profile of solid networks in the oral cavity (lipid matrix for sustained release) (Deore, Kavitha, & Tamizhmani, 2010; Wen, Nokhodchi, & Rajabi-siahboomi, 2010). Also, NLCs can be formulated by some main solid lipids comprising fatty acids, such as stearic acid, cholesterol, and waxes (e.g. cetyl palmitate) (Fang, Al-Suwayeh,& Fang, 2013). Stearic acid,\nalso recognized as octadecanoic acid, is a biocompatible and foodgrade substance and is one of the most common long-chain fatty acids, found in animal tissues and vegetable fats. The melting point of stearic acid is 69.6 C and thus it is a good candidate for delivery purposes (Hu et al., 2005).\nLiquid lipids (oils) are the key elements within the formulation of NLCs and mostly comprise digestible oils. There are two typical types of liquid lipids for the application in NLCs: saturated oils, such as medium chain triglycerides (MCTs), paraffin oil, isopropyl palmitate plus capric/caprylic triglyceride; and unsaturated oils like oleic acid, squalene, vegetable and seed oils (Fang et al., 2013; Müller et al., 2002a).\nMCTs, such as Miglyol® 812, are most commonly used in NLCs as a liquid lipid. These oils have a similar structure with some common solid lipids like the glyceryl behenate (Compritol® 888 ATO) and can be easily combined with them in the inner phase of NLCs. The MCTs have a high stability against oxidation, however incorporating them in healthy formulations (like functional foods) can be problematic due to their saturation. Saturated oils can raise the blood cholesterol levels and lead to cardiovascular diseases. On the other hand, NLCs can be formulated by some healthy fatty acids, such as oleic acid and linoleic acid. These are usually obtained by the hydrolysis of various animal and vegetable lipids (e.g. olive) followed by separation of the liquid fatty acids. Oleic and linoleic acid are susceptible to oxidation more than triglycerides due to their unsaturated nature (DiNicolantonio, Lucan, & O’Keefe, 2016; Zhuang et al., 2010).\nIt is of utmost importance to prepare NLC structures by including novel, biocompatible and healthy oils in the formulations that are intended to be applied in the food and related industries. Some healthy bioactive ingredients, such as a-tocopherol (vitamin E) or other agents can be used as liquid lipids in the inner phase of NLCs. Tocopherols are functional elements and possess the advantages of being available, affordable, augmenting the solubility of lipophilic ingredients and to be applied in large-scale production processes (Tsai et al., 2012). The plants and seeds oil, such as soybean oil, olive oil, sunflower oil, sesame oil and cottonseed oil are also proper candidates for the production of NLCs (Joshi, Pathak, Sharma, & Patravale, 2008; Manea et al., 2014; Pardeike et al., 2011; Yang et al., 2013; Zhang et al., 2008). Food manufacturers are eager to utilize plant and seed oils in the formulation of NLCs according to their cheapness, commercial availability, and bearing some healthy compounds like antioxidants.\n4.2. Emulsifiers\nEmulsifiers have a key role in the stabilization of lipid matrix systems. Most of the properties of SLNs and NLCs, such as particle size distribution, zeta-potential of the particle, encapsulation efficiency, optical and physical characteristics along with the stability of SLNs and NLCs are influenced by emulsifiers. As a result, picking a proper emulsifier is necessary for designing the intended type of SLNs and NLCs (Müller et al., 2002a,b).\nFood-grade emulsifiers, which are employed in the food and pharmaceutical areas are classified into two main categories: macromolecular emulsifiers, also known as biopolymers (e.g., whey protein concentrate) and small molecule surfactants (e.g., Tween series). Currently, biopolymers have been utilized as typical emulsifiers for fabricating stable emulsions. Proteins (e.g., whey protein and casein) and polysaccharides (e.g., gums and pectin) are main biopolymers that can be used individually or in combination with the formulation of oil in water emulsions (Esfanjani, Jafari, Assadpoor, & Mohammadi, 2015; Mohammadi, Jafari, Esfanjani, & Akhavan, 2016b). Nevertheless, macromolecule biopolymers have not been wieldy introduced into NLC formulations, which can be\nreferred to their very slow rate of diffusivity and adsorbance onto the fresh interface in comparison to small surfactants (Jafari, He, & Bhandari, 2007). Consequently, the hydrophilic small molecule surfactants are normally implemented as emulsifying agents in the formulation of NLCs. Lipophilic surfactants, such as Span 80, Myverol® 18-04K, Span 20, Span 40, and Span 60 are also used to develop NLCs (Fang et al., 2013).\nThere are three broad classes of hydrophilic surfactants used in the formulation of SLNs and NLCs including (1) neutral, e.g., lecithin, (2) ionic, e.g., sodium cholate, sodium lauryl sulfate, sodium deoxycholate (SDC), sodium dodecyl sulfate (SDS), sodium oleate and sodium taurodeoxycholate, and (3) non-ionic, e.g., poloxamer 188, poloxamer 407, Tween 20, Tween 40, Tween 80, Pluronic F127, Brij78, Tego care 450, and Solutol HS15 (Fang et al., 2013; Shah, Eldridge, Palombo, & Harding, 2015; Souto, Wissing, Barbosa, & Müller, 2004).\nWhen the SLNs and NLCs are generated, the surface properties would change dramatically during the formation of nano-particles via solidification (cooling crystallization) of colloid nano-droplets. Thus, it is necessary to create a resistant membrane around the lipids with the help of surfactants. Lecithin is a major neutral surfactant that is abundantly used in SLN and NLC formulations. Yet, the formed bilayer membrane by only using lecithin could not reach the particle surface. Therefore, it is highly recommended to use a mixture of ionic and non-ionic surfactants with lecithin in order to obtain the best results.\nThe electrostatic repulsion potential among the surfactantcovered nanoparticles results in their elevated stability (Ninham, 1999). Generally, two layers (stern layer as an ion layer and diffuse layer as loosely associated ions) encompass the particles in solution commonly known as electrical double layer. Another factor influencing the stability of delivery systems is the zeta-potential, which is actually the electrostatic potential in the outer limit separating the stern layer and the diffuse layer (Mitri, Shegokar, Gohla, Anselmi, & Müller, 2011). Ionic surfactants are accommodated within the stern layer of the SLNs and NLCs and therefore the charge of SLNs and NLCs mainly emanates from the ionic properties of the surfactants. The highest zeta-potential can be achieved by using sufficient ionic surfactants within the stern layer. Thereupon, the ionic surfactant can increase the electrostatic repulsion potential energy among the particles and yield stable SLNs and NLCs. On the other hand, steric stabilization of SLNs and NLCs can be provided by the non-ionic surfactants. Small particles can also be provided by applying non-ionic surfactants due to the formation of a closely packed mixed film by intercalation of the non-ionic surfactant molecules between the phospholipids monolayer. In conclusion, by using a mixture of surfactants (ionic, non-ionic, and neutral), stable SLNs and NLCs could be obtained rather than stabilizing the intended system by employing only one surfactant (Han, Li, Yin, Liu, & Xu, 2008; Tan, Billa, Roberts, & Burley, 2010)."
    }, {
      "heading" : "5. Production techniques for SLNs and NLCs",
      "text" : "Different techniques have been developed for the production of SLNs and NLCs with miscellaneous sizes and shapes. The size of particles scales directly with their functions but it is not the unique parameter considered to compare the various techniques. The production process is identical for both systems (SLNs and NLCs). Although there are several methods adopted in order to prepare SLNs and NLCs (Table 3), two processes of the high-pressure homogenization plus hot and cold methods are prevalently implemented to fabricate these delivery systems (Torchilin, 2006).\nSLNs and NLCs are principally produced by two main methods: (i) the first method needs high energy, which is provided by high energy machines, such as high-pressure homogenization (hot and\nTable 3 Overview of production methods for SLNs and NLCs.\nTechnology Process steps Reference\nHot homogenization technique\n1. Melting of the lipid and dissolving/dispersing of the bioactive in the lipid 2. Dispersing of the bioactive -loaded lipid in hot aqueous surfactant mixture 3. Pre-mix using a stirrer to form a coarse pre-emulsion 4. High pressure homogenization at temperature above lipid melting point 5. Hot O/W nanoemulsion 6. Solidification of the nanoemulsion by cooling down to room temperature\n(Radtke & Müller, 2001)\nCold homogenization technique\n1. Melting the lipid and dissolving/dispersing of the bioactive in the lipid 2. Solidification of the bioactive loaded lipid in liquid nitrogen or dry ice 3. Grinding in a powder mill (50e100 mm) 4. Dispersing the powder in an aqueous surfactant dispersion medium (pre-mix) 5. High pressure homogenization at room temperature or below\n(Mehnert & M€ader, 2001)\nHigh pressure homogenization\n1. The lipid is pushed with high pressure (100e2000 bars) through a very high shear stress 2. Disruption of particles down to the submicrometer or nanometer range\n(Liedtke, Wissing, Müller, & M€ader, 2000)\nSolvent emulsification eevaporation method 1. Lipids and bioactive compound are dissolved in a water immiscible organic solvent with low boiling point\n2. The solution is then emulsified in the aqueous emulsifier solution. 3. Evaporation in a rotary evaporator at 50e60 C\n(Wissing et al., 2004)\nSolvent emulsificationdiffusion technique 1. Both the solvent and water are mutually saturated in order to ensure the initial thermodynamic equilibrium of both liquids.\n2. Lipid and bioactive are dissolved in water saturated solvent and this organic phase is stirred using mechanical stirrer. 3. After the formulation of O/W emulsion, water in typical ratio from 1:5 to 1:10, is added to the system in order to allow solvent diffusion into the continuous phase, thus leading to the aggregation of the lipid in the nanoparticles.\n(Hu et al., 2002)\nMicroemulsion technique 1. Lipids are melted and bioactive is incorporated in molten lipid. 2. A mixture of water, co-surfactant(s) and the surfactant is heated to the same temperature as the lipids\nand added under mild stirring to the lipid melt. 3. A transparent, thermodynamically stable system is formed when the compounds are mixed in the\ncorrect ratios for microemulsion formation. Thus the microemulsion is the basis for the formation of nanoparticles of a requisite size.\n4. This microemulsion is then dispersed in a cold aqueous medium under mild mechanical mixing of hot microemulsion with water in a ratio in the range 1:25e1:50.\n(Joshi et al., 2008; Pardeike, Hommoss, & Müller, 2009)\nMelting dispersion method 1. Bioactive and solid lipid are melted in an organic solvent regarded as oil phase. Simultaneously water phase is also heated to the same temperature as oil phase.\n2. The oil phase is added to a small volume of water phase and the resulting emulsion is stirred at high speed for few hours. 3. The emulsion is cooled down to room temperature to yield nanoparticles\n(Müller et al., 2002a,b)\nUltrasonication technique 1. The core material is melted 2. Addition of phospholipids along with an aqueous medium 3. Dispersing the melted material at increased temperature by ultra-sonication.\n(Puglia et al., 2017)\nSolvent injection 1. Lipids are dissolved in a water-miscible solvent (e.g. acetone, isopropanol and methanol) or watermiscible solvent mixture\n2. Quickly injected into an aqueous solution of surfactants through an injection needle\n(Schubert & Müller-Goymann, 2003)\nDouble emulsion technique\n1. bioactive (mainly hydrophilic ones) is dissolved in aqueous solution emulsified in melted lipid. 2. The primary emulsion is stabilized by adding stabilizer that is dispersed in aqueous phase containing\nhydrophilic emulsifier 3. Emulsion is stirred and filtered.\n(Garcıa-Fuentes, Torres, & Alonso, 2003)\ncold temperature), high-speed homogenization and ultrasound. (ii) the second method namely low energy include using the controllable mixtures at low stirring (usually by using a magnetic stirrer) such as micro-emulsions, phase inversion temperature (PIT) and solvent based methods (solvent diffusion and solvent injection); besides NLCs can be produced by membrane contactors as a source of low energy (Weyhers, Mehnert, Hahn, & Müller, 1995; Müller et al., 2002a,b)."
    }, {
      "heading" : "5.1. High energy methods",
      "text" : "One of the most commonmethods for producing SLNs and NLCs is high-pressure homogenization method (HPH). Concerning the temperature of HPH process, SLNs and NLCs can be prepared by hot or cold homogenization. The hot homogenization method is carried out at a temperature above the melting point of the utilized lipid. As mentioned earlier, NLCs are composed of an inner phase (liquid and solid lipid) together with an outer phase (emulsifier and water). In order to fabricate NLC structures via the hot\nhomogenization method, initially, the lipid matrix containing a mixture of solid and liquid lipid is mixed with the bioactive ingredient by a simple stirrer at a temperature above the melting point of lipid matrix. This combination is then dispersed in a hot surfactant solution at the same temperature to form a hot preemulsion by high-speed stirring. Subsequently, the final preemulsion is then fed to the high-pressure homogenizer. Finally, the NLCs are formed by cooling the hot O/W nano-emulsion in the ambient temperature, cold water or a heat exchanger to solidify the lipid droplet and precipitate the lipid nanoparticles, which leads to the formation of crystals (Müller et al., 2002b).\nSensitive ingredients cannot be encapsulated by hot homogenization method. In this manner, cold homogenization is an ideal alternative to the nanoencapsulation of heat-sensitive ingredients occurring at temperatures below the melting point of the lipid. Moreover, this method is best applied to hydrophilic bioactive ingredients. This practice has already been tested for SLNs, however its application in the preparation of NLCs has not been reported. In this method, bioactive ingredients are dispersed into a melt lipid\nphase followed by quick cooling of the overall lipid mixture. After solidification, the bulk lipid is milled to produce lipid microparticles. The obtained lipid micro-particles are then scattered in a cold surfactant solution by simple stirring to yield a macrosuspension. Eventually, the micro-particles are degraded by the help of the high-pressure homogenizer apparatus and SLNs are achieved (Müller et al., 2002b). The cold homogenization of SLNs requires high energy input which in turn demands the harsh homogenization processing conditions. On the contrary, the fine monodispersed miniscule particles can be prepared by homogenizing molten lipids through hot homogenization method (Shah et al., 2015).\nHigh-speed homogenization and ultrasonication: similar to high-pressure homogenization, this technique can be developed for the production of NLCs. In this method, the molten lipids are gradually added into the aqueous phase during blending via highspeed homogenization and subsequently, the NLCs are prepared by ultrasonication of produced coarse lipid particles from high-speed homogenization (Chen, Tsai, Huang, & Fang, 2010).\nAnother simple laboratory method for the fabrication of NLCs is called emulsification-evaporation, which involves an organic solvent together with high-speed/high-pressure homogenization or ultrasound technique. In this approach, the oil phase and bioactive ingredients are dissolved in a water-immiscible organic solvent (like chloroform and cyclohexane) to form a pre-emulsion. The resulted pre-emulsion is then emulsified in the aqueous phase containing hydrophilic surfactant via high-speed/high-pressure homogenization or ultrasound technique. Subsequently, the organic solvent of this solution is discarded by agitation at a certain temperature (emulsifying temperature) and definite time period (emulsifying time). Lastly, the prepared emulsion is cooled in the aqueous phase under mechanical agitation in order to fabricate NLCs (Wissing et al., 2004)."
    }, {
      "heading" : "5.2. Low energy methods",
      "text" : "There is a thermodynamically stable method for the preparation of NLCs, so-called microemulsion in which these emulsions are spontaneously formed and no mechanical energy is required to initiate their formation. In this method, the lipids comprising a surfactant (and a co-surfactant, if needed) and the water phase are heated separately, mixed and subsequently titrated with the surfactant until a transparent micro-emulsion is observable. The hot micro-emulsion is then diluted with cold water (2e3 C) under stirring so that solid lipid and/or surfactant is obtained in the micelle (Chen et al., 2006).\nPhase Inversion Temperature (PIT) technique is considered as a low energy method for producing nano-emulsions. Also, PIT has the potential for the production of NLCs. In this procedure, surfactant, lipids and water mixture are heated nearly above the phase inversion temperature and then the cooling process starts with continuous stirring. The mixture is treated with three temperature cycles, starting from the room temperature to PIT during magnetic stirring. In the last cycle, when the mixture is cooled, ice cold deionized water (0 C) is added to the combination. The rapid cooling-dilution action leads to the formation of NLCs (Heurtault, Saulnier, Pech, Proust, & Benoit, 2002).\nSolvent diffusion and solvent injection are two typical solvent-based, low energy methods that can be used for the production of NLCs. Solvent diffusion includes the usage of partially water-soluble solvents (e.g., benzyl alcohol, butyl lactate, isobutyric acid and isovaleric acid). Concisely, the lipid phase (blend of liquid and solid lipid) together with the bioactive ingredient are dissolved in partially hydrophilic solvents. The final product is poured into the aqueous phase (water plus the surfactant) under stirring\n(usually by magnetic stirrer). The obtained suspension is then cooled to the ambient temperature in order to form NLCs. Solvent injection approach is akin to solvent diffusion technique, with the exception that in solvent injection the solvent that scatters quickly in water (e.g., DMSO and ethanol) is used to dissolve lipids (Hejri et al., 2013; Hu et al., 2002, 2004).\nHaving discussed the beneficial application of these novel nanostructures, they also have their own deficiencies and limitations in their further implementation in the food sector. For instance, SLNs exhibit unpredictable gelation behavior and low space for the entrapment of bioactives owing to their dense crystalline architecture and propensity to polymorphic transitions resulting to the unwanted liberation of bioactive compounds (Aditya, Espinosa, & Norton, 2017; Gharibzahedi & Jafari, 2017). In addition to the advantages offered by NLCs, there may be some challenges in the employment of NLCs in the food area, such as the proper selection of food-grade ingredients, which can endure processing circumstances, crystallines may penetrate the liquid oil moiety in the system during collision and lead to the aggregation of particles termed “partial coalescence” causing instability. Ultimately, due to the increasing tendency of lowering the saturated fat crystals in food products, this solid portion of the NLCs must be chosen wisely to cover the human health concerns (Katouzian & Jafari, 2016; Puglia et al., 2017; Tamjidi et al., 2013)."
    }, {
      "heading" : "6. Bioavailability and potential toxicity of SLNs/NLCs",
      "text" : "About a decade ago, there was a positive attitude toward the Nano definition. Nevertheless, the public viewpoint toward nanotechnology has changed due to the potential toxicity induced by some nanomaterials (Jafari & McClements, 2017; Katouzian & Jafari, 2016; Mokhtari, Jafari, & Assadpour, 2017).\nGenerally, there are three elemental routes by which consumers are exposed to the fabricated nanomaterials including oral, dermal and respiratory pathways (Jafari, 2017). Following the oral administration of nanofoods, due to their extraordinarily small size they are rapidly absorbed by enterocytes in the intestine (high rate of bioavailability) and enter the circulatory system (Fig. 4). Accordingly, they are carried throughout the body andmay be deposited in different organs or excreted from the body. Some strategies that are responsible for the higher rate of bioavailability when using SLNs and NLCs for transports of nutrients are indeed based on the conception of absorption process in the gastrointestinal tract. As illustrated in Fig. 4, these mechanisms are uptake by Peyer's patches, circulation of P-glycoprotein efflux from intestinal epithelium, and targeting of intestinal lymphoid tissue plus the development in digestive solubility (Jafari & McClements, 2017; Park, Garcia, Shin, & Kim, 2017; Yang, Liu, & Liu, 2017).\nThe long-term effects of consuming SLN and NLC structures are still an enigma and the studies determining their toxicological effects are in the infant stage. However, there are some works, which have discussed the effect of these nanocarriers inside the biological systems. As an example, Madureira et al. (2016) analyzed the imparted genotoxicity by SLNs (prepared by witepsol and carnauba waxes) bearing rosmarinic acid (RA) via in vivo tests. Lymphocytes were tested for possible DNA damage and apoptosis. Wistar rats were gavaged with free and encapsulated RA, subsequently samples were collected from their blood, urine and some tissues. In a nutshell, the levels below 1.5 mg/ml revealed no toxicity, however concentrations higher than that induced genotoxicity observed by the necrosis of Lymphocytes. In another study, Rahman et al. (2014) looked at toxicological effect of NLCs loaded with zerumbone (an anti-inflammatory phytochemical substance) following its oral administration to BALB/c mice. They isolated samples from the kidney, liver, spleen, heart, brain tissues and analyzed the serum\nbiochemical parameters to assess the possible toxicity of the administered nanostructures. To sum up, the oral levels of 100 and 200 mg/kg were considered safe in the tested animals and the lethal dose (LD50) of the utilized nanostructure was reported to be higher than 200 mg/kg and thus detected to be safe for consumption via the oral route.\nAs a final point, the structure of the utilized SLNs and NLCs must be studied in detail prior to their application in food systems since it influences the liberation and absorption of the payloads dramatically (Assadpour, Jafari, & Maghsoudlou, 2017; Mehrnia, Jafari, Makhmal-Zadeh, & Maghsoudlou, 2017; Mokhtari et al., 2017)."
    }, {
      "heading" : "7. Conclusion and future trends",
      "text" : "SLNs and NLCs have opened new horizons in the field of nanoencapsulation of bioactive compounds in the food industry, with the ability to boost the encapsulation efficiency and bioavailability of the food bioactives. SLNs can incorporate complex bioactive molecules in themselves. As each entrappedmolecule has its own physicochemical and stability features, the preparation method should also be based on the encased nutrient to enhance the encapsulation efficiency as well as the stability of the core material; thus the environmental conditions plus the processing terms should be meticulously defined before the nanoencapsulation process. Furthermore, NLCs are capable of overcoming the disadvantages of other lipid-based nanovehicles; such as low bioactives loading, low encapsulation efficiency, and system instability. If the physical conditions of the entrapped lipid are controlled, burst release may be achieved, which is useful in the food sector, like flavor release due to heating in ready-meals. Both\nNLC and SLN ingredients can be provided from low-cost, naturally occurring food components which can be employed as green formulations in the food and pharmaceutical industries. Meanwhile, there are also some challenges in utilizing these nanovesicles. For instance, the formulations need to be carefully designed since the ranges of approved emulsifiers used in the food products are narrow. Besides, the stability of nanocarriers should be tested as most food components undergo the conditions of pasteurization or sterilization during the processing. Ultimately, case-by-case toxicological assays and clinical trials must be carried out to assure that these novel nano-vehicles are safe for consumption."
    } ],
    "references" : [ {
      "title" : "Encapsulation systems for the delivery of hydrophilic nutraceuticals: Food application",
      "author" : [ "N. Aditya", "Y.G. Espinosa", "I.T. Norton" ],
      "venue" : "Biotechnology Ad-",
      "citeRegEx" : "Aditya et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Aditya et al\\.",
      "year" : 2017
    }, {
      "title" : "Solid lipid nanoparticles (SLNs): Delivery vehicles for food bioactives",
      "author" : [ "N. Aditya", "S. Ko" ],
      "venue" : "RSC Advances,",
      "citeRegEx" : "Aditya and Ko,? \\Q2015\\E",
      "shortCiteRegEx" : "Aditya and Ko",
      "year" : 2015
    }, {
      "title" : "Evaluation of folic acid release from spray dried powder particles of pectin-whey protein nano-capsules",
      "author" : [ "E. Assadpour", "Jafari", "S.-M", "Y. Maghsoudlou" ],
      "venue" : null,
      "citeRegEx" : "Assadpour et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Assadpour et al\\.",
      "year" : 2017
    }, {
      "title" : "Mucoadhesive nanostructured lipid",
      "author" : [ "S. Chanburee", "W. Tiyaboonchai" ],
      "venue" : null,
      "citeRegEx" : "Chanburee and Tiyaboonchai,? \\Q2016\\E",
      "shortCiteRegEx" : "Chanburee and Tiyaboonchai",
      "year" : 2016
    }, {
      "title" : "Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid",
      "author" : [ "Chen", "C.-C", "Tsai", "T.-H", "Huang", "Z.-R", "Fang", "J.-Y" ],
      "venue" : null,
      "citeRegEx" : "Chen et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Chen et al\\.",
      "year" : 2010
    }, {
      "title" : "Nanotechnology in nutraceuticals",
      "author" : [ "H. Chen", "J. Weiss", "F. Shahidi" ],
      "venue" : null,
      "citeRegEx" : "Chen et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Chen et al\\.",
      "year" : 2006
    }, {
      "title" : "Encapsulation of Vitamin B2 in solid lipid nanoparticles using supercritical CO2",
      "author" : [ "R. Couto", "V. Alvarez", "F. Temelli" ],
      "venue" : "The Journal of Supercritical Fluids,",
      "citeRegEx" : "Couto et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Couto et al\\.",
      "year" : 2017
    }, {
      "title" : "Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs",
      "author" : [ "S. Das", "W.K. Ng", "R.B. Tan" ],
      "venue" : "European Journal of Pharmaceutical Sciences,",
      "citeRegEx" : "Das et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Das et al\\.",
      "year" : 2012
    }, {
      "title" : "Preparation and evaluation of sustained release matrix tablets of tramadol hydrochloride using glyceryl palmitostearate",
      "author" : [ "R. Deore", "K. Kavitha", "T. Tamizhmani" ],
      "venue" : "Tropical Journal of Pharmaceutical Research,",
      "citeRegEx" : "Deore et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Deore et al\\.",
      "year" : 2010
    }, {
      "title" : "The evidence for saturated fat and for sugar related to coronary heart disease",
      "author" : [ "J.J. DiNicolantonio", "S.C. Lucan", "J.H. O'Keefe" ],
      "venue" : "Progress in Cardiovascular Diseases,",
      "citeRegEx" : "DiNicolantonio et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "DiNicolantonio et al\\.",
      "year" : 2016
    }, {
      "title" : "Fabrication and characterization of low crystalline curcumin loaded lipid nanoparticles. Rutgers University-Graduate School-New Brunswick",
      "author" : [ "Y. Du" ],
      "venue" : null,
      "citeRegEx" : "Du,? \\Q2011\\E",
      "shortCiteRegEx" : "Du",
      "year" : 2011
    }, {
      "title" : "Nanoencapsulation of saffron extract through double-layered multiple emulsions of pectin and whey protein concentrate",
      "author" : [ "A.F. Esfanjani", "S.M. Jafari", "E. Assadpoor", "A. Mohammadi" ],
      "venue" : "Journal of Food Engineering,",
      "citeRegEx" : "Esfanjani et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Esfanjani et al\\.",
      "year" : 2015
    }, {
      "title" : "Nanostructured lipid carriers (NLCs) for drug delivery and targeting",
      "author" : [ "Fang", "C.-L. A", "S. Al-Suwayeh", "J.-Y" ],
      "venue" : "Recent Patents on Nanotechnology,",
      "citeRegEx" : "Fang et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Fang et al\\.",
      "year" : 2013
    }, {
      "title" : "Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)",
      "author" : [ "Fang", "J.-Y", "C.-L", "Liu", "C.-H", "Su", "Y.-H" ],
      "venue" : "European Journal of Pharmaceutics and Biopharmaceutics,",
      "citeRegEx" : "Fang et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Fang et al\\.",
      "year" : 2008
    }, {
      "title" : "Nanoencapsulation of food ingredients using lipid based delivery systems",
      "author" : [ "M. Fathi", "M. Mozafari", "M. Mohebbi" ],
      "venue" : "Trends in Food Science & Technology,",
      "citeRegEx" : "Fathi et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Fathi et al\\.",
      "year" : 2012
    }, {
      "title" : "Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules",
      "author" : [ "M. Garcıa-Fuentes", "D. Torres", "M. Alonso" ],
      "venue" : "Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "Garcıa.Fuentes et al\\.,? \\Q2003\\E",
      "shortCiteRegEx" : "Garcıa.Fuentes et al\\.",
      "year" : 2003
    }, {
      "title" : "Vitamin B12-loaded solid lipid nanoparticles as a drug carrier in cancer therapy",
      "author" : [ "L. Genç", "H.M. Kutlu", "G. Güney" ],
      "venue" : "Pharmaceutical Development and Technology,",
      "citeRegEx" : "Genç et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Genç et al\\.",
      "year" : 2015
    }, {
      "title" : "The importance of minerals in human nutrition: Bioavailability, food fortification, processing effects and nanoencapsulation",
      "author" : [ "S.M.T. Gharibzahedi", "S.M. Jafari" ],
      "venue" : "Trends in Food Science & Technology,",
      "citeRegEx" : "Gharibzahedi and Jafari,? \\Q2017\\E",
      "shortCiteRegEx" : "Gharibzahedi and Jafari",
      "year" : 2017
    }, {
      "title" : "Encapsulation in the food industry: A review",
      "author" : [ "F. Gibbs", "S.K. Inteaz Alli", "Mulligan", "Catherine N", "Bernard" ],
      "venue" : "International Journal of Food Sciences and Nutrition,",
      "citeRegEx" : "Gibbs et al\\.,? \\Q1999\\E",
      "shortCiteRegEx" : "Gibbs et al\\.",
      "year" : 1999
    }, {
      "title" : "Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers",
      "author" : [ "F. Han", "S. Li", "R. Yin", "H. Liu", "L. Xu" ],
      "venue" : "Colloids and Surfaces a: Physicochemical and Engineering Aspects,",
      "citeRegEx" : "Han et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Han et al\\.",
      "year" : 2008
    }, {
      "title" : "Optimisation of the formulation of b-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method",
      "author" : [ "A. Hejri", "A. Khosravi", "K. Gharanjig", "M. Hejazi" ],
      "venue" : "Food Chemistry,",
      "citeRegEx" : "Hejri et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Hejri et al\\.",
      "year" : 2013
    }, {
      "title" : "A novel phase inversion-based process for the preparation of lipid nanocarriers",
      "author" : [ "B. Heurtault", "P. Saulnier", "B. Pech", "Proust", "J.-E", "Benoit", "J.-P" ],
      "venue" : "Pharmaceutical Research,",
      "citeRegEx" : "Heurtault et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Heurtault et al\\.",
      "year" : 2002
    }, {
      "title" : "Preparation and characterization of solid lipid nanoparticles containing peptide",
      "author" : [ "F. Hu", "Y. Hong", "H. Yuan" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Hu et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Hu et al\\.",
      "year" : 2004
    }, {
      "title" : "Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system",
      "author" : [ "Hu", "F.-Q", "Jiang", "S.-P", "Du", "Y.-Z", "H. Yuan", "Ye", "Y.-Q", "S. Zeng" ],
      "venue" : "Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "Hu et al\\.,? \\Q2005\\E",
      "shortCiteRegEx" : "Hu et al\\.",
      "year" : 2005
    }, {
      "title" : "Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization",
      "author" : [ "F. Hu", "H. Yuan", "H. Zhang", "M. Fang" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Hu et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Hu et al\\.",
      "year" : 2002
    }, {
      "title" : "Nanoencapsulation technologies for the food and nutraceutical industries",
      "author" : [ "S. Jafari" ],
      "venue" : null,
      "citeRegEx" : "Jafari,? \\Q2017\\E",
      "shortCiteRegEx" : "Jafari",
      "year" : 2017
    }, {
      "title" : "Effectiveness of encapsulating biopolymers to produce sub-micron emulsions by high energy emulsification techniques",
      "author" : [ "S.M. Jafari", "Y. He", "B. Bhandari" ],
      "venue" : "Food Research International,",
      "citeRegEx" : "Jafari et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Jafari et al\\.",
      "year" : 2007
    }, {
      "title" : "Chapter one-nanotechnology approaches for increasing nutrient bioavailability",
      "author" : [ "S. Jafari", "D. McClements" ],
      "venue" : "Advances in food and nutrition research (Vol. 81, pp. 1e30)",
      "citeRegEx" : "Jafari and McClements,? \\Q2017\\E",
      "shortCiteRegEx" : "Jafari and McClements",
      "year" : 2017
    }, {
      "title" : "A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne",
      "author" : [ "A. Jain", "N.K. Garg", "P. Kesharwani", "A.K. Jain", "P. Nirbhavane", "R.K. Tyagi" ],
      "venue" : "Drug Development and Industrial Pharmacy,",
      "citeRegEx" : "Jain et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Jain et al\\.",
      "year" : 2016
    }, {
      "title" : "Nanostructured lipid carriers and their current application in targeted drug delivery",
      "author" : [ "P. Jaiswal", "B. Gidwani", "A. Vyas" ],
      "venue" : "Artificial Cells, Nanomedicine, and Biotechnology,",
      "citeRegEx" : "Jaiswal et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Jaiswal et al\\.",
      "year" : 2016
    }, {
      "title" : "Effect of palm or coconut solid lipid nanoparticles (SLNs) on growth of Lactobacillus plantarum in milk",
      "author" : [ "Jo", "Y.-J", "Choi", "M.-J", "Kwon" ],
      "venue" : "Korean Journal for Food Science of Animal Resources,",
      "citeRegEx" : "Jo et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Jo et al\\.",
      "year" : 2015
    }, {
      "title" : "Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject",
      "author" : [ "M. Joshi", "S. Pathak", "S. Sharma", "V. Patravale" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Joshi et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Joshi et al\\.",
      "year" : 2008
    }, {
      "title" : "Nanoencapsulation as a promising approach for targeted delivery and controlled release of vitamins",
      "author" : [ "I. Katouzian", "S.M. Jafari" ],
      "venue" : "Trends in Food Science",
      "citeRegEx" : "Katouzian and Jafari,? \\Q2016\\E",
      "shortCiteRegEx" : "Katouzian and Jafari",
      "year" : 2016
    }, {
      "title" : "Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure",
      "author" : [ "A. Kovacevic", "S. Savic", "G. Vuleta", "R. Müller", "C.M. Keck" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Kovacevic et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Kovacevic et al\\.",
      "year" : 2011
    }, {
      "title" : "Protection and viability of fruit seeds oils by nanostructured lipid carrier (NLC) nanosuspensions",
      "author" : [ "O. Krasodomska", "P. Paolicelli", "S. Cesa", "M.A. Casadei", "C. Jungnickel" ],
      "venue" : "Journal of Colloid and Interface Science,",
      "citeRegEx" : "Krasodomska et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Krasodomska et al\\.",
      "year" : 2016
    }, {
      "title" : "Release study of selected terpenes from nanostructured lipid carriers",
      "author" : [ "E. n", "E. Sikora", "J. Ogonowski", "M. Tabaszewska", "Ł. Skoczylas" ],
      "venue" : "Colloids and Surfaces a: Physicochemical and Engineering Aspects,",
      "citeRegEx" : "n et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "n et al\\.",
      "year" : 2016
    }, {
      "title" : "Influence of high pressure homogenisation equipment on nanodispersions characteristics",
      "author" : [ "K. ader" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "ader,? \\Q2000\\E",
      "shortCiteRegEx" : "ader",
      "year" : 2000
    }, {
      "title" : "Brucea javanica oil-loaded nanostructure lipid carriers (BJO NLCs): Preparation, characterization and in vitro evaluation",
      "author" : [ "W. Lv", "S. Zhao", "H. Yu", "N. Li", "V.M. Garamus", "Y Chen" ],
      "venue" : "Colloids and Surfaces a: Physicochemical and Engineering Aspects",
      "citeRegEx" : "Lv et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Lv et al\\.",
      "year" : 2016
    }, {
      "title" : "Characterization of solid lipid nanoparticles produced with carnauba wax for rosmarinic acid oral delivery",
      "author" : [ "A.R. Madureira", "D.A. Campos", "P. Fonte", "S. Nunes", "F. Reis", "Gomes", "A. M" ],
      "venue" : "RSC Advances,",
      "citeRegEx" : "Madureira et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Madureira et al\\.",
      "year" : 2015
    }, {
      "title" : "Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: In vitro and animal approaches",
      "author" : [ "A.R. Madureira", "S. Nunes", "D.A. Campos", "J.C. Fernandes", "C. Marques", "M Zuzarte" ],
      "venue" : "International Journal of Nanomedicine,",
      "citeRegEx" : "Madureira et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Madureira et al\\.",
      "year" : 2016
    }, {
      "title" : "Antioxidant and antimicrobial activities of green tea extract loaded into nanostructured lipid carriers",
      "author" : [ "Manea", "A.-M", "B.S. Vasile", "A. Meghea" ],
      "venue" : "Comptes Rendus Chimie,",
      "citeRegEx" : "Manea et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Manea et al\\.",
      "year" : 2014
    }, {
      "title" : "Structured emulsion-based delivery systems: Controlling the digestion and release of lipophilic food components",
      "author" : [ "D.J. McClements", "Y. Li" ],
      "venue" : "Advances in Colloid and Interface Science,",
      "citeRegEx" : "McClements and Li,? \\Q2010\\E",
      "shortCiteRegEx" : "McClements and Li",
      "year" : 2010
    }, {
      "title" : "Solid lipid nanoparticles: Production, characterization and applications",
      "author" : [ "W. Mehnert", "K. M€ader" ],
      "venue" : "Advanced Drug Delivery Reviews,",
      "citeRegEx" : "Mehnert and M€ader,? \\Q2001\\E",
      "shortCiteRegEx" : "Mehnert and M€ader",
      "year" : 2001
    }, {
      "title" : "Rheological and release properties of double nano-emulsions containing crocin prepared with Angum gum, Arabic gum and whey protein",
      "author" : [ "Mehrnia", "M.-A", "Jafari", "S.-M", "B.S. Makhmal-Zadeh", "Y. Maghsoudlou" ],
      "venue" : "Food Hydrocolloids,",
      "citeRegEx" : "Mehrnia et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Mehrnia et al\\.",
      "year" : 2017
    }, {
      "title" : "Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance",
      "author" : [ "K. Mitri", "R. Shegokar", "S. Gohla", "C. Anselmi", "R.H. Müller" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Mitri et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Mitri et al\\.",
      "year" : 2011
    }, {
      "title" : "Nanoencapsulation of olive leaf phenolic compounds through WPCepectin complexes and evaluating their release",
      "author" : [ "A. Mohammadi", "S.M. Jafari", "E. Assadpour", "A.F. Esfanjani" ],
      "venue" : "rate. International Journal of Biological Macromolecules,",
      "citeRegEx" : "Mohammadi et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Mohammadi et al\\.",
      "year" : 2016
    }, {
      "title" : "Application of nano-encapsulated olive leaf extract in controlling the oxidative stability of soybean oil",
      "author" : [ "A. Mohammadi", "S.M. Jafari", "A.F. Esfanjani", "S. Akhavan" ],
      "venue" : "Food Chemistry,",
      "citeRegEx" : "Mohammadi et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Mohammadi et al\\.",
      "year" : 2016
    }, {
      "title" : "Development of a nutraceutical nano-delivery system through emulsification/internal gelation of alginate",
      "author" : [ "S. Mokhtari", "S.M. Jafari", "E. Assadpour" ],
      "venue" : "Food Chemistry,",
      "citeRegEx" : "Mokhtari et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Mokhtari et al\\.",
      "year" : 2017
    }, {
      "title" : "Nanocarrier technologies: Frontiers of nanotherapy",
      "author" : [ "M.R. Mozafari" ],
      "venue" : null,
      "citeRegEx" : "Mozafari,? \\Q2006\\E",
      "shortCiteRegEx" : "Mozafari",
      "year" : 2006
    }, {
      "title" : "Solid lipid nanoparticles (SLN) for controlled drug deliveryea review of the state of the art",
      "author" : [ "R.H. Eller", "K. Ma Eder", "S. Gohla" ],
      "venue" : "European Journal of Pharmaceutics and Biopharmaceutics,",
      "citeRegEx" : "Eller et al\\.,? \\Q2000\\E",
      "shortCiteRegEx" : "Eller et al\\.",
      "year" : 2000
    }, {
      "title" : "Nanostructured lipid matrices for improved microencapsulation of drugs",
      "author" : [ "R. Müller", "M. Radtke", "S. Wissing" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Müller et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Müller et al\\.",
      "year" : 2002
    }, {
      "title" : "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations",
      "author" : [ "R.H. Müller", "M. Radtke", "S.A. Wissing" ],
      "venue" : "Advanced Drug Delivery Reviews,",
      "citeRegEx" : "Müller et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Müller et al\\.",
      "year" : 2002
    }, {
      "title" : "Antifungal activity of Zataria multiflora essential oil-loaded solid lipid nanoparticles in-vitro condition",
      "author" : [ "M. Nasseri", "S. Golmohammadzadeh", "H. Arouiee", "M.R. Jaafari", "H. Neamati" ],
      "venue" : "Iranian Journal of Basic Medical Sciences,",
      "citeRegEx" : "Nasseri et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Nasseri et al\\.",
      "year" : 2016
    }, {
      "title" : "Curcuminoids-loaded lipid nanoparticles: Novel approach towards malaria treatment",
      "author" : [ "A.P. Nayak", "W. Tiyaboonchai", "S. Patankar", "B. Madhusudhan", "E.B. Souto" ],
      "venue" : "Colloids and Surfaces B: Biointerfaces,",
      "citeRegEx" : "Nayak et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Nayak et al\\.",
      "year" : 2010
    }, {
      "title" : "On progress in forces since the DLVO theory",
      "author" : [ "B. Ninham" ],
      "venue" : "Advances in Colloid and Interface Science,",
      "citeRegEx" : "Ninham,? \\Q1999\\E",
      "shortCiteRegEx" : "Ninham",
      "year" : 1999
    }, {
      "title" : "Quercetin loaded nanostructured lipid carrier for food fortification: Preparation, characterization and in vitro study",
      "author" : [ "S. Ni", "R. Sun", "G. Zhao", "Q. Xia" ],
      "venue" : "Journal of Food Process Engineering,",
      "citeRegEx" : "Ni et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Ni et al\\.",
      "year" : 2015
    }, {
      "title" : "Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol",
      "author" : [ "D. Pandita", "S. Kumar", "N. Poonia", "V. Lather" ],
      "venue" : "Food Research International,",
      "citeRegEx" : "Pandita et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Pandita et al\\.",
      "year" : 2014
    }, {
      "title" : "Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products",
      "author" : [ "J. Pardeike", "A. Hommoss", "R.H. Müller" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Pardeike et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Pardeike et al\\.",
      "year" : 2009
    }, {
      "title" : "Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application",
      "author" : [ "J. Pardeike", "S. Weber", "T. Haber", "J. Wagner", "H. Zarfl", "H Plank" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Pardeike et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Pardeike et al\\.",
      "year" : 2011
    }, {
      "title" : "Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3",
      "author" : [ "S.J. Park", "C.V. Garcia", "G.H. Shin", "J.T. Kim" ],
      "venue" : "Food Chemistry",
      "citeRegEx" : "Park et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Park et al\\.",
      "year" : 2017
    }, {
      "title" : "Characterization of ergocalciferol loaded solid lipid nanoparticles",
      "author" : [ "M.R. Patel", "S. Martin-Gonzalez", "M. Fernanda" ],
      "venue" : "Journal of Food Science,",
      "citeRegEx" : "Patel et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Patel et al\\.",
      "year" : 2012
    }, {
      "title" : "Encapsulation of vitamin A palmitate in nanostructured lipid carrier (NLC)-effect of surfactant concentration on the formulation properties",
      "author" : [ "A. Pezeshki", "B. Ghanbarzadeh", "M. Mohammadi", "I. Fathollahi", "H. Hamishehkar" ],
      "venue" : "Advanced Pharmaceutical Bulletin,",
      "citeRegEx" : "Pezeshki et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Pezeshki et al\\.",
      "year" : 2014
    }, {
      "title" : "Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs",
      "author" : [ "C.J. Porter", "N.L. Trevaskis", "W.N. Charman" ],
      "venue" : "Nature Reviews Drug Discovery,",
      "citeRegEx" : "Porter et al\\.,? \\Q2007\\E",
      "shortCiteRegEx" : "Porter et al\\.",
      "year" : 2007
    }, {
      "title" : "Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system",
      "author" : [ "C.W. Pouton" ],
      "venue" : "European Journal of Pharmaceutical Sciences,",
      "citeRegEx" : "Pouton,? \\Q2006\\E",
      "shortCiteRegEx" : "Pouton",
      "year" : 2006
    }, {
      "title" : "Nanostructured lipid carriers (NLC) as vehicles for topical administration of sesamol: In vitro percutaneous absorption study and evaluation of antioxidant activity",
      "author" : [ "C. Puglia", "M.R. Lauro", "A. Offerta", "L. Crascì", "L. Micicch e", "Panico", "A. M" ],
      "venue" : "Planta Medica,",
      "citeRegEx" : "Puglia et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Puglia et al\\.",
      "year" : 2017
    }, {
      "title" : "Impact of lipid nanoparticle physical state on particle aggregation and b-carotene degradation: Potential limitations of solid lipid nanoparticles",
      "author" : [ "C. Qian", "E.A. Decker", "H. Xiao", "D.J. McClements" ],
      "venue" : "Food Research International,",
      "citeRegEx" : "Qian et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Qian et al\\.",
      "year" : 2013
    }, {
      "title" : "Nanostructured lipid drug carriers",
      "author" : [ "M. Radtke", "R.H. Müller" ],
      "venue" : "New Drugs,",
      "citeRegEx" : "Radtke and Müller,? \\Q2001\\E",
      "shortCiteRegEx" : "Radtke and Müller",
      "year" : 2001
    }, {
      "title" : "Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model",
      "author" : [ "H.S. Rahman", "A. Rasedee", "H.H. Othman", "M.S. Chartrand", "F. Namvar", "Yeap", "S. K" ],
      "venue" : "BioMed Research International,",
      "citeRegEx" : "Rahman et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Rahman et al\\.",
      "year" : 2014
    }, {
      "title" : "Delivery systems for liquid food products",
      "author" : [ "L. Sagalowicz", "M.E. Leser" ],
      "venue" : "Current Opinion in Colloid & Interface Science,",
      "citeRegEx" : "Sagalowicz and Leser,? \\Q2010\\E",
      "shortCiteRegEx" : "Sagalowicz and Leser",
      "year" : 2010
    }, {
      "title" : "Solvent injection as a new approach for manufacturing lipid nanoparticleseevaluation of the method and process parameters",
      "author" : [ "M. Schubert", "C. Müller-Goymann" ],
      "venue" : "European Journal of Pharmaceutics and Biopharmaceutics,",
      "citeRegEx" : "Schubert and Müller.Goymann,? \\Q2003\\E",
      "shortCiteRegEx" : "Schubert and Müller.Goymann",
      "year" : 2003
    }, {
      "title" : "Lipid nanoparticles: Production, characterization and stability",
      "author" : [ "R. Shah", "D. Eldridge", "E. Palombo", "I. Harding" ],
      "venue" : null,
      "citeRegEx" : "Shah et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Shah et al\\.",
      "year" : 2015
    }, {
      "title" : "Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine",
      "author" : [ "S. Singh", "A.K. Dobhal", "A. Jain", "J.K. Pandit", "S. Chakraborty" ],
      "venue" : "Chemical and Pharmaceutical Bulletin,",
      "citeRegEx" : "Singh et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Singh et al\\.",
      "year" : 2010
    }, {
      "title" : "Polymorphic behaviour of Compritol 888 ATO as bulk lipid and as SLN and NLC",
      "author" : [ "E. Souto", "W. Mehnert", "R. Müller" ],
      "venue" : "Journal of Microencapsulation,",
      "citeRegEx" : "Souto et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Souto et al\\.",
      "year" : 2006
    }, {
      "title" : "Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery",
      "author" : [ "E. Souto", "S. Wissing", "C. Barbosa", "R. Müller" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Souto et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Souto et al\\.",
      "year" : 2004
    }, {
      "title" : "Solid lipid nanoparticles containing copaiba oil and allantoin: Development and role of nanoencapsulation on the antifungal activity",
      "author" : [ "G. Svetlichny", "I. Külkamp-Guerreiro", "S. Cunha", "F. Silva", "K. Bueno", "A Pohlmann" ],
      "venue" : "Die Pharmazie-an International Journal of Pharmaceutical Sciences,",
      "citeRegEx" : "Svetlichny et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Svetlichny et al\\.",
      "year" : 2015
    }, {
      "title" : "Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules",
      "author" : [ "F. Tamjidi", "M. Shahedi", "J. Varshosaz", "A. Nasirpour" ],
      "venue" : "Innovative Food Science & Emerging Technologies,",
      "citeRegEx" : "Tamjidi et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Tamjidi et al\\.",
      "year" : 2013
    }, {
      "title" : "Surfactant effects on the physical characteristics of amphotericin B-containing nanostructured lipid carriers. Colloids and surfaces a",
      "author" : [ "S. Tan", "N. Billa", "C. Roberts", "J. Burley" ],
      "venue" : "Physicochemical and Engineering Aspects,",
      "citeRegEx" : "Tan et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Tan et al\\.",
      "year" : 2010
    }, {
      "title" : "Oral delivery of anticancer drugs: Challenges and opportunities",
      "author" : [ "K. Thanki", "R.P. Gangwal", "A.T. Sangamwar", "S. Jain" ],
      "venue" : "Journal of Controlled Release,",
      "citeRegEx" : "Thanki et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Thanki et al\\.",
      "year" : 2013
    }, {
      "title" : "Nanoparticulates as drug carriers",
      "author" : [ "V.P. Torchilin" ],
      "venue" : "Imperial college press",
      "citeRegEx" : "Torchilin,? \\Q2006\\E",
      "shortCiteRegEx" : "Torchilin",
      "year" : 2006
    }, {
      "title" : "Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain",
      "author" : [ "Tsai", "M.-J", "Wu", "P.-C", "Huang", "Y.-B", "Chang", "J.-S", "Lin", "C.-L", "Y.-H" ],
      "venue" : "targeting. International Journal of Pharmaceutics,",
      "citeRegEx" : "Tsai et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Tsai et al\\.",
      "year" : 2012
    }, {
      "title" : "Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems",
      "author" : [ "M. Üner" ],
      "venue" : "Die Pharmazie-an International Journal of Pharmaceutical Sciences,",
      "citeRegEx" : "Üner,? \\Q2006\\E",
      "shortCiteRegEx" : "Üner",
      "year" : 2006
    }, {
      "title" : "Physicochemical characterization, identification and improved photo-stability of alpha-lipoic acid-loaded nanostructured lipid carrier",
      "author" : [ "J. Wang", "J. Tang", "X. Zhou", "Q. Xia" ],
      "venue" : "Drug Development and Industrial Pharmacy,",
      "citeRegEx" : "Wang et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2014
    }, {
      "title" : "Solid lipid nanoparticles as delivery systems for bioactive food components",
      "author" : [ "J. Weiss", "E.A. Decker", "D.J. McClements", "K. Kristbergsson", "T. Helgason", "T. Awad" ],
      "venue" : "Food Biophysics,",
      "citeRegEx" : "Weiss et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Weiss et al\\.",
      "year" : 2008
    }, {
      "title" : "Oral extended release hydrophilic matrices: Formulation and design. In Oral controlled release formulation design and drug Delivery: Theory to practice",
      "author" : [ "X. Wen", "A. Nokhodchi", "A. Rajabi-siahboomi" ],
      "venue" : null,
      "citeRegEx" : "Wen et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Wen et al\\.",
      "year" : 2010
    }, {
      "title" : "Solid lipid nanoparticlesddetermination of in vivo toxicity",
      "author" : [ "H. Weyhers", "W. Mehnert", "H. Hahn", "R. Müller" ],
      "venue" : "In Proc First World Meeting APGI/ APV, Budapest (pp. 489e490)",
      "citeRegEx" : "Weyhers et al\\.,? \\Q1995\\E",
      "shortCiteRegEx" : "Weyhers et al\\.",
      "year" : 1995
    }, {
      "title" : "Solid lipid nanoparticles for parenteral drug delivery",
      "author" : [ "S. Wissing", "O. Kayser", "R. Müller" ],
      "venue" : "Advanced Drug Delivery Reviews,",
      "citeRegEx" : "Wissing et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Wissing et al\\.",
      "year" : 2004
    }, {
      "title" : "Development of free-flowing peppermint essential oilloaded hollow solid lipid micro-and nanoparticles via atomization with carbon dioxide",
      "author" : [ "J. Yang", "O.N. Ciftci" ],
      "venue" : "Food Research International,",
      "citeRegEx" : "Yang and Ciftci,? \\Q2016\\E",
      "shortCiteRegEx" : "Yang and Ciftci",
      "year" : 2016
    }, {
      "title" : "Hyaluronic acidcoated nanostructured lipid carriers for targeting paclitaxel to cancer",
      "author" : [ "Yang", "X.-y", "Li", "Y.-x", "M. Li", "L. Zhang", "Feng", "L.-x", "N. Zhang" ],
      "venue" : "Cancer Letters,",
      "citeRegEx" : "Yang et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Yang et al\\.",
      "year" : 2013
    }, {
      "title" : "Effects of aroma compounds and lipid composition on release of functional substances encapsulated in nanostructured lipid carriers lipolyzed by lipase",
      "author" : [ "Yang", "T.-S", "Liu", "T.-T", "H.-I" ],
      "venue" : "Food Hydrocolloids,",
      "citeRegEx" : "Yang et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Yang et al\\.",
      "year" : 2017
    }, {
      "title" : "Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10hydroxycamptothecin by spray-drying",
      "author" : [ "X. Zhang", "W. Pan", "L. Gan", "C. Zhu", "Y. Gan", "S. Nie" ],
      "venue" : "Chemical and Pharmaceutical Bulletin,",
      "citeRegEx" : "Zhang et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2008
    }, {
      "title" : "Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability",
      "author" : [ "Zhuang", "C.-Y", "N. Li", "M. Wang", "Zhang", "X.-N", "Pan", "W.-S", "Peng", "J.-J" ],
      "venue" : "International Journal of Pharmaceutics,",
      "citeRegEx" : "Zhuang et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Zhuang et al\\.",
      "year" : 2010
    } ],
    "referenceMentions" : [ {
      "referenceID" : 18,
      "context" : "Today, the benefits of nanotechnology has influenced many branches in the food sector such as, packaging, bioactives compound delivery systems, and designing optimized formulations with the aim of increased bioavailability (Gibbs et al., 1999).",
      "startOffset" : 223,
      "endOffset" : 243
    }, {
      "referenceID" : 14,
      "context" : "On the other hand, lipid-based nanoparticles bear the advantages of (Fathi et al., 2012; Mohammadi, Jafari, Esfanjani, & Akhavan, 2016a): biocompatibility more encapsulation efficiency targeted effect modified release low toxicity lack of organic solvent for the formulation ease of continuous production",
      "startOffset" : 68,
      "endOffset" : 136
    }, {
      "referenceID" : 82,
      "context" : "Among the mentioned lipid nanoparticles, SLNs contain lipid droplets that are fully crystallized and have an organized crystalline structure with the bioactive components accommodated within the lipid matrix (Weiss et al., 2008).",
      "startOffset" : 208,
      "endOffset" : 228
    }, {
      "referenceID" : 38,
      "context" : "Some of the advantages of the employment of SLNs as efficient nanovehicles are listed below (Madureira et al., 2015; Mozafari, 2006; Sagalowicz & Leser, 2010).",
      "startOffset" : 92,
      "endOffset" : 158
    }, {
      "referenceID" : 48,
      "context" : "Some of the advantages of the employment of SLNs as efficient nanovehicles are listed below (Madureira et al., 2015; Mozafari, 2006; Sagalowicz & Leser, 2010).",
      "startOffset" : 92,
      "endOffset" : 158
    }, {
      "referenceID" : 82,
      "context" : "However, like other nanocarriers, SLNs also have their own disadvantages which are (Aditya & Ko, 2015; Weiss et al., 2008):",
      "startOffset" : 83,
      "endOffset" : 122
    }, {
      "referenceID" : 10,
      "context" : "✓ The ingredients should not have a negative effect on the sensory properties of SLNs-incorporated foods (Du, 2011).",
      "startOffset" : 105,
      "endOffset" : 115
    }, {
      "referenceID" : 75,
      "context" : "✓ Stability of SLNs must be examined during processing and storage of foods against mechanical and physicochemical stresses, such as pressure, stirring, thermal processing, light, drying, freezing, pH, and environmental storage conditions (Tamjidi et al., 2013).",
      "startOffset" : 239,
      "endOffset" : 261
    }, {
      "referenceID" : 38,
      "context" : ", 2013), beta-carotene in 50:50 cocoa butter and hydrogenated palm oil (Qian, Decker, Xiao, & McClements, 2013), resveratrol in stearic acid (Pandita, Kumar, Poonia, & Lather, 2014), rosmarinic acid within carnauba wax (Madureira et al., 2015), curcuminoids in tristearin, trimyristin and glyceryl monostearate (Nayak, Tiyaboonchai, Patankar, Madhusudhan, & Souto, 2010), copaiba oil and allantoin in cetyl palmitate (Svetlichny et al.",
      "startOffset" : 219,
      "endOffset" : 243
    }, {
      "referenceID" : 74,
      "context" : ", 2015), curcuminoids in tristearin, trimyristin and glyceryl monostearate (Nayak, Tiyaboonchai, Patankar, Madhusudhan, & Souto, 2010), copaiba oil and allantoin in cetyl palmitate (Svetlichny et al., 2015), Zataria multiflora essential oil within glyceril mono stearate and Precirol ATO 5 (Nasseri, Golmohammadzadeh, Arouiee, Jaafari, & Neamati, 2016) and peppermint essential oil loaded in fully hydrogenated soybean oil (Yang& Ciftci, 2016).",
      "startOffset" : 181,
      "endOffset" : 206
    }, {
      "referenceID" : 14,
      "context" : "Some of the advantages of employing NLCs in the nanoencapsulation of food components are (Fathi et al., 2012; http:// www.pharmasol-berlin.de/lipidnano.php3; Müller et al., 2002a):",
      "startOffset" : 89,
      "endOffset" : 179
    }, {
      "referenceID" : 74,
      "context" : "Copaiba oil and allantoin Copaiba oil and cetyl palmitate High homogenization Nanoencapsulation improved the antifungal activity of copaiba oil, which was enhanced by the presence of allantoin (Svetlichny et al., 2015)",
      "startOffset" : 193,
      "endOffset" : 218
    }, {
      "referenceID" : 38,
      "context" : "5% (w/v) of lipid and 2% (v/v) of ploysorbate 80 (Madureira et al., 2015)",
      "startOffset" : 49,
      "endOffset" : 73
    }, {
      "referenceID" : 56,
      "context" : "the oral bioavailability of resveratrol as compared to the intact suspension (Pandita et al., 2014)",
      "startOffset" : 77,
      "endOffset" : 99
    }, {
      "referenceID" : 14,
      "context" : "NLCs, as one of the lipid-based encapsulation vehicles, can be successfully used as a fundamental delivery system for the fortification of foods accommodating a variety of bioavailable ingredients (Fathi et al., 2012).",
      "startOffset" : 197,
      "endOffset" : 217
    }, {
      "referenceID" : 37,
      "context" : "Some of the recent studies performed in this area are entrapment of alpha-lipoic acid in glycerin monostearate and glyceride (Wang, Tang, Zhou, & Xia, 2014), astaxanthin in glyceryl behenate and oleic acid (Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2014), beta-carotene in palmitic acid and corn oil (Hejri, Khosravi, Gharanjig, & Hejazi, 2013), quercetin in glyceryl monostearate and caprylic capric triglyceride (Ni, Sun, Zhao, & Xia, 2015), green tea extract in glyceryl stearate, cetyl palmitate, grape seed oil and sea buckthorn oil (Manea, Vasile, & Meghea, 2014), rutin in cocoa butter and oleic acid (Babazadeh, Ghanbarzadeh, & Hamishehkar, 2016), mono, di and triterpenes in beeswax together with caprylic/capric triglyceride (Laso n, Sikora, Ogonowski, Tabaszewska, & Skoczylas, 2016), cold pressed fruit and kernel seed oils in paraffin oil, beeswax, glycerol and mono, di and tri acylglycerols (Krasodomska, Paolicelli, Cesa, Casadei, & Jungnickel, 2016), Brucea javanica oil incorporated in glyceryl monostearate, medium-chain triglyceride, stearic acid plus Cremophor EL (Lv et al., 2016), and curcumin accommodation within soybean phospholipids, glyceryl monostearate, medium chain triglyceride and steric acid with the aim of improving oral delivery (Chanburee & Tiyaboonchai, 2016).",
      "startOffset" : 1085,
      "endOffset" : 1102
    }, {
      "referenceID" : 28,
      "context" : "effect in acne therapy in physiological conditions (Jain et al., 2016)",
      "startOffset" : 51,
      "endOffset" : 70
    }, {
      "referenceID" : 37,
      "context" : "exhibit improved BJO bioavailability (Lv et al., 2016)",
      "startOffset" : 37,
      "endOffset" : 54
    }, {
      "referenceID" : 55,
      "context" : "Quercetin Glyceryl monostearate and caprylic capric triglyceride High pressure homogenization The nanostructure showed potential application in soft beverage, also Particle size remained relatively steady in simulated beverage solutions for 2 months (Ni et al., 2015)",
      "startOffset" : 250,
      "endOffset" : 267
    }, {
      "referenceID" : 81,
      "context" : "a-lipoic acid (ALA) Glycerin monostearate, glyceride and glyceryl triacetate Hot high pressure homogenization The photostability of ALA was significantly enhanced by NLC formulation compared to the free ALA (Wang et al., 2014)",
      "startOffset" : 207,
      "endOffset" : 226
    }, {
      "referenceID" : 40,
      "context" : "antimicrobial agent with improved activity within NLCs (Manea et al., 2014)",
      "startOffset" : 55,
      "endOffset" : 75
    }, {
      "referenceID" : 20,
      "context" : "b-carotene Palmitic acid and corn oil Solvent diffusion The optimum formulations indicated minimum particle size (8e15 nm) and low b-carotene degradation (0e3%) (Hejri et al., 2013) I.",
      "startOffset" : 161,
      "endOffset" : 181
    }, {
      "referenceID" : 90,
      "context" : "Monostearin is also used as an emulsifier, which is able to induce a controlled release behavior (Zhuang et al., 2010).",
      "startOffset" : 97,
      "endOffset" : 118
    }, {
      "referenceID" : 23,
      "context" : "6 C and thus it is a good candidate for delivery purposes (Hu et al., 2005).",
      "startOffset" : 58,
      "endOffset" : 75
    }, {
      "referenceID" : 12,
      "context" : "There are two typical types of liquid lipids for the application in NLCs: saturated oils, such as medium chain triglycerides (MCTs), paraffin oil, isopropyl palmitate plus capric/caprylic triglyceride; and unsaturated oils like oleic acid, squalene, vegetable and seed oils (Fang et al., 2013; Müller et al., 2002a).",
      "startOffset" : 274,
      "endOffset" : 315
    }, {
      "referenceID" : 90,
      "context" : "Oleic and linoleic acid are susceptible to oxidation more than triglycerides due to their unsaturated nature (DiNicolantonio, Lucan, & O’Keefe, 2016; Zhuang et al., 2010).",
      "startOffset" : 109,
      "endOffset" : 170
    }, {
      "referenceID" : 79,
      "context" : "Tocopherols are functional elements and possess the advantages of being available, affordable, augmenting the solubility of lipophilic ingredients and to be applied in large-scale production processes (Tsai et al., 2012).",
      "startOffset" : 201,
      "endOffset" : 220
    }, {
      "referenceID" : 40,
      "context" : "The plants and seeds oil, such as soybean oil, olive oil, sunflower oil, sesame oil and cottonseed oil are also proper candidates for the production of NLCs (Joshi, Pathak, Sharma, & Patravale, 2008; Manea et al., 2014; Pardeike et al., 2011; Yang et al., 2013; Zhang et al., 2008).",
      "startOffset" : 157,
      "endOffset" : 281
    }, {
      "referenceID" : 58,
      "context" : "The plants and seeds oil, such as soybean oil, olive oil, sunflower oil, sesame oil and cottonseed oil are also proper candidates for the production of NLCs (Joshi, Pathak, Sharma, & Patravale, 2008; Manea et al., 2014; Pardeike et al., 2011; Yang et al., 2013; Zhang et al., 2008).",
      "startOffset" : 157,
      "endOffset" : 281
    }, {
      "referenceID" : 87,
      "context" : "The plants and seeds oil, such as soybean oil, olive oil, sunflower oil, sesame oil and cottonseed oil are also proper candidates for the production of NLCs (Joshi, Pathak, Sharma, & Patravale, 2008; Manea et al., 2014; Pardeike et al., 2011; Yang et al., 2013; Zhang et al., 2008).",
      "startOffset" : 157,
      "endOffset" : 281
    }, {
      "referenceID" : 89,
      "context" : "The plants and seeds oil, such as soybean oil, olive oil, sunflower oil, sesame oil and cottonseed oil are also proper candidates for the production of NLCs (Joshi, Pathak, Sharma, & Patravale, 2008; Manea et al., 2014; Pardeike et al., 2011; Yang et al., 2013; Zhang et al., 2008).",
      "startOffset" : 157,
      "endOffset" : 281
    }, {
      "referenceID" : 12,
      "context" : "Lipophilic surfactants, such as Span 80, Myverol 18-04K, Span 20, Span 40, and Span 60 are also used to develop NLCs (Fang et al., 2013).",
      "startOffset" : 117,
      "endOffset" : 136
    }, {
      "referenceID" : 12,
      "context" : ", poloxamer 188, poloxamer 407, Tween 20, Tween 40, Tween 80, Pluronic F127, Brij78, Tego care 450, and Solutol HS15 (Fang et al., 2013; Shah, Eldridge, Palombo, & Harding, 2015; Souto, Wissing, Barbosa, & Müller, 2004).",
      "startOffset" : 117,
      "endOffset" : 219
    }, {
      "referenceID" : 54,
      "context" : "The electrostatic repulsion potential among the surfactantcovered nanoparticles results in their elevated stability (Ninham, 1999).",
      "startOffset" : 116,
      "endOffset" : 130
    }, {
      "referenceID" : 78,
      "context" : "Although there are several methods adopted in order to prepare SLNs and NLCs (Table 3), two processes of the high-pressure homogenization plus hot and cold methods are prevalently implemented to fabricate these delivery systems (Torchilin, 2006).",
      "startOffset" : 228,
      "endOffset" : 245
    }, {
      "referenceID" : 85,
      "context" : "Evaporation in a rotary evaporator at 50e60 C (Wissing et al., 2004)",
      "startOffset" : 46,
      "endOffset" : 68
    }, {
      "referenceID" : 70,
      "context" : "On the contrary, the fine monodispersed miniscule particles can be prepared by homogenizing molten lipids through hot homogenization method (Shah et al., 2015).",
      "startOffset" : 140,
      "endOffset" : 159
    }, {
      "referenceID" : 85,
      "context" : "Lastly, the prepared emulsion is cooled in the aqueous phase under mechanical agitation in order to fabricate NLCs (Wissing et al., 2004).",
      "startOffset" : 115,
      "endOffset" : 137
    }, {
      "referenceID" : 5,
      "context" : "The hot micro-emulsion is then diluted with cold water (2e3 C) under stirring so that solid lipid and/or surfactant is obtained in the micelle (Chen et al., 2006).",
      "startOffset" : 143,
      "endOffset" : 162
    }, {
      "referenceID" : 20,
      "context" : ", DMSO and ethanol) is used to dissolve lipids (Hejri et al., 2013; Hu et al., 2002, 2004).",
      "startOffset" : 47,
      "endOffset" : 90
    }, {
      "referenceID" : 64,
      "context" : "Ultimately, due to the increasing tendency of lowering the saturated fat crystals in food products, this solid portion of the NLCs must be chosen wisely to cover the human health concerns (Katouzian & Jafari, 2016; Puglia et al., 2017; Tamjidi et al., 2013).",
      "startOffset" : 188,
      "endOffset" : 257
    }, {
      "referenceID" : 75,
      "context" : "Ultimately, due to the increasing tendency of lowering the saturated fat crystals in food products, this solid portion of the NLCs must be chosen wisely to cover the human health concerns (Katouzian & Jafari, 2016; Puglia et al., 2017; Tamjidi et al., 2013).",
      "startOffset" : 188,
      "endOffset" : 257
    }, {
      "referenceID" : 25,
      "context" : "Generally, there are three elemental routes by which consumers are exposed to the fabricated nanomaterials including oral, dermal and respiratory pathways (Jafari, 2017).",
      "startOffset" : 155,
      "endOffset" : 169
    }, {
      "referenceID" : 47,
      "context" : "As a final point, the structure of the utilized SLNs and NLCs must be studied in detail prior to their application in food systems since it influences the liberation and absorption of the payloads dramatically (Assadpour, Jafari, & Maghsoudlou, 2017; Mehrnia, Jafari, Makhmal-Zadeh, & Maghsoudlou, 2017; Mokhtari et al., 2017).",
      "startOffset" : 210,
      "endOffset" : 326
    } ],
    "year" : 0,
    "abstractText" : "Background: Lipid nanoparticles are innovative delivery systems, which are similar to the prevalently used emulsions, with the differences in size and structure in which the water-insoluble core is dispersed in a combination of solid and liquid lipids stabilized by surfactants. Solid lipid nanoparticles (SLNs) plus nanostructured lipid carriers (NLCs) are novel and promising nano-vehicles, which are of great interest to be applied in the food sector owing to their exclusive properties, as investigated in this revision. Scope and approach: LNs and NLCs are produced to unite the advantages of structures like liposomes and emulsions and they can be formulated to achieve desirable protection and release of food bioactive ingredients. This review highlights the pros and cons of using SLNs and NLCs in the food industry. Furthermore, the commonly applied production methods and formulations along with the recently conducted studies in the field of food science and technology are underlined. Key findings and conclusions: These nano-vehicles have the potential to be employed in the food industrial applications in regard to their beneficial properties like simple production technology, low cost and scale up ability. These nanocarriers have been mostly applied in the pharmaceutical industries and are recently being utilized in the food sector, which seems to have great impacts on this industry as well as their commercialization in the near future. © 2017 Elsevier Ltd. All rights reserved.",
    "creator" : "Elsevier"
  }
}